AYTU Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally...

Stats
Dagens volum	21 130.00
Gjennomsnittsvolum	20 769.00
Markedsverdi	16.76M
EPS	$0 ( 2024-02-14 )
Neste inntjeningsdato	( $-0.640 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.750
ATR14	$0.0250 (0.83%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-31	Pyszczymuka Greg	Buy	208	Common Shares
2024-03-31	Pyszczymuka Greg	Sell	208	Restricted Stock Units
2023-12-31	Pyszczymuka Greg	Buy	209	Common Shares
2023-12-31	Pyszczymuka Greg	Sell	209	Restricted Stock Units
2023-09-30	Pyszczymuka Greg	Buy	208	Common Shares

INSIDER POWER
31.03
Last 94 transactions
Buy: 33 552 785 \| Sell: 39 056 468

Aytu BioScience Inc Korrelasjon

10 Mest positive korrelasjoner
REYN	0.959
SRNGW	0.954
IBRX	0.951
VWE	0.949
HCAQ	0.948
JAGX	0.946
CHKEL	0.945
PROC	0.943
MAGS	0.942
LGMK	0.941

10 Mest negative korrelasjoner
SMAP	-0.957
OVLY	-0.955
VAQC	-0.953
IPVIU	-0.948
SY	-0.948
GENQ	-0.948
ATEC	-0.946
HPLTU	-0.944
SJ	-0.943
IGTA	-0.943

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Aytu BioScience Inc Økonomi

Annual	2023
Omsetning:	$107.40M
Bruttogevinst:	$66.63M (62.04 %)
EPS:	$-5.11

FY	2023
Omsetning:	$107.40M
Bruttogevinst:	$66.63M (62.04 %)
EPS:	$-5.11

FY	2022
Omsetning:	$96.67M
Bruttogevinst:	$52.28M (54.08 %)
EPS:	$-1 499.10

FY	2021
Omsetning:	$65.63M
Bruttogevinst:	$29.20M (44.49 %)
EPS:	$-0.174

Financial Reports:

No articles found.

Aytu BioScience Inc

Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency; Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension; and ZolpiMist, an oral spray for the treatment of insomnia. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.

Sanntidsoppdatering for Aytu BioScience Inc [AYTU]

Upcoming Earnings Alert